# Observational Study Regarding the Combination of Fluoropyrimidine and Bevacizumab in Patients With mCRC

> **NCT07494578** · — · ACTIVE_NOT_RECRUITING · sponsor: **Fondazione Policlinico Universitario Agostino Gemelli IRCCS** · enrollment: 300 (estimated)

## Conditions studied

- Colon Cancer Metastatic

## Interventions

- **DRUG:** Fluoropyrimidine

## Key facts

- **NCT ID:** NCT07494578
- **Lead sponsor:** Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-07-01
- **Primary completion:** 2027-07-01
- **Final completion:** 2027-08-01
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07494578

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07494578, "Observational Study Regarding the Combination of Fluoropyrimidine and Bevacizumab in Patients With mCRC". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07494578. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*